Top Markets
#1 Status Status +19.39%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.43%
#3 GoPlus Security GoPlus Security +12.56%
#4 Fake World Assets Fake World Assets +10.48%
#5 DMT-NAT DMT-NAT +9.49%
#6 Ontology Gas Ontology Gas +9.19%
#7 Provenance Blockchain Provenance Blockchain +6.74%
#8 o1.exchange o1.exchange +6.72%
#9 Janction Janction +6.56%
#10 B3 (Base) B3 (Base) +5.41%
Coin of the day
Status Status
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Sesen Bio, Inc. Sesen Bio, Inc.

Sesen Bio, Inc.

SESN
Classifica tra le azioni #34230
Sesen Bio, Inc. is a clinical-stage biotechnology firm deeply involved in the... Sesen Bio, Inc. is a clinical-stage biotechnology firm deeply involved in the creation, advancement, and eventual market launch of targeted fusion protein therapeutics (TFPTs). Their primary aim is to combat various forms of cancer. Their flagship experimental drug, Vicineum, is a locally administered targeted fusion protein currently undergoing Phase III clinical trials. It targets several conditions, including non-muscle invasive bladder cancer that has not responded to bacillus Calmette-Guérin (BCG) treatment, non-muscle invasive carcinoma in situ of the bladder in patients who previously received BCG, and squamous cell carcinoma affecting the head and neck region. Another promising candidate, VB6-845d, is being developed to address a range of anti-epithelial cell adhesion molecule-positive solid tumors. Sesen Bio is also collaborating with Leiden University Medical Center on the joint development of an imaging agent. Originally incorporated in 2008, the company operated as Eleven Biotherapeutics, Inc. before rebranding as Sesen Bio, Inc. in May 2018. Its corporate headquarters are situated in Cambridge, Massachusetts.
Prezzo delle azioni
$0.6288
Ultima sincronizzazione: 2023-03-07
Capitalizzazione di mercato
$6.00M
Variazione (1 giorno)
7.29%
Variazione (1 anno)
0.00%
Paese
US
Scambia Sesen Bio, Inc. (SESN)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per Sesen Bio, Inc. (SESN)
L’azione Sesen Bio, Inc. (simbolo: SESN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 17, 2026.
Una quota di SESN acquistata prima di Aug 17, 2026 equivale oggi a 0 quote di SESN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 0 -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0 -
BE